PIK3CA and cervical squamous cell carcinoma: Prospective longitudinal studies are needed to define if the knowledge of TP53 and/or PIK3CA status could provide relevant information for the management of individual patients with different histotypes of adenocarcinoma and squamous cell carcinoma of the cervix.